WT1 (WILMS TUMOR 1) PEPTIDE IMMUNOTHERAPY FOR CHILDHOOD RHABDOMYOSARCOMA: A Case Report

By Ohta Hideaki   Hashii Yoshiko   Yoneda Akihiro   Takizawa Sachiko   Kusuki Shigenori   Tokimasa Sadao   Fukuzawa Masahiro   Tsuboi Akihiro   Murao Ayako   Oka Yoshihiro   Oji Yusuke   Aozasa Katsuyuki   Nakatsuka Shin-ichi   Sugiyama Haruo   Ozono Keiichi  

Pediatric Hematology and Oncology, Vol. 26, Iss. 1, 2009-01 ,pp. : 74-83

Informa Healthcare

Access to resources Recommend Favorite

Myogenesis in Wilms’ tumor is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway

By  

Pediatric and Developmental Pathology, Vol. 7, Iss. 5, 2004-11 ,pp. : 549-549

Springer Publishing Company

Access to resources Recommend Favorite

EXPRESSION OF WILMS TUMOR GENE (W T1) IN CHILDREN WITH ACUTE LEUKEMIA

By Im Ho Joon   Lee Hahng  

Pediatric Hematology and Oncology, Vol. 16, Iss. 2, 1999-03 ,pp. : 109-118

Informa Healthcare

Access to resources Recommend Favorite

Myogenesis in Wilms Tumors Is Associated with Mutations of the WT1 Gene and Activation of Bcl-2 and the Wnt Signaling Pathway

By Fukuzawa Ryuji  

Pediatric and Developmental Pathology, Vol. 7, Iss. 2, 2004-04 ,pp. : 125-137

Springer Publishing Company

Access to resources Recommend Favorite

Tissue Expression of MLH1, PMS2, MSH2, and MSH6 Proteins and Prognostic Value of Microsatellite Instability in Wilms Tumor: Experience of 45 Cases

By Diniz Gulden  

Pediatric Hematology and Oncology, Vol. 30, Iss. 4, 2013-04 ,pp. : 273-284

Informa Healthcare

Access to resources Recommend Favorite